Professor Ruth Plummer, Honorary Consultant Medical Oncologist and Director of The Sir Bobby Robson Cancer Trials Research Centre, Newcastle Hospitals, was bestowed the prestigious Targeted Anticancer Therapies 2021 Honorary Award at the European Society of Medical Oncology Targeted Anticancer Therapies Virtual Congress 2021.
This was in recognition of Prof Plummer’s extensive trial activity, which has taken many new cancer drugs into the clinic that have become standard treatments with proven patient benefit.
Notably, Prof Plummer is the Principle Investigator for the trial, for which the Sir Bobby Robson Cancer Trials Research Centre was the first site worldwide to treat a patient with Achilles Therapeutics’ novel clonal neo-antigen Advanced Therapy.
